IDEXX Laboratories, Inc. Profile Avatar - Palmy Investing

IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Produ…
Medical - Diagnostics & Research
US, Westbrook [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 33% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -0.11 1.57 1.57
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 0.06 2.01 2.01
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 5.67 18.88 17.87
Cash -12.46 4.78 5.46
Capex 7.02 -0.36 -0.39
Free Cash Flow -22.55 2.03 2.62
Revenue 6.92 11.60 10.85
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 5.41 0.62 0.58
Operating Margin 13.97 0.31 0.27
ROA 17.73 0.07 0.06
ROE 14.59 0.15 0.13
ROIC 10.40 0.09 0.08
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of IDXX is permitted for members.
5 Growth
The "Growth Entry" for the Focus of IDXX is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of IDXX is permitted for members.
End of IDXX's Analysis
CIK: 874716 CUSIP: 45168D104 ISIN: US45168D1046 LEI: - UEI: -
Secondary Listings